Global Artificial Organs Market - Growth, Trends, and Forecasts (2017 - 2022)

The global artificial organs market was valued at USD 13.76 billion in 2014 and is projected to reach USD 21.10 billion by 2019, growing at a CAGR of 8.93% during the forecast period from 2015 to 2021.

Global Artificial Organs Market-Market Dynamics

The report details several factors driving and restraining the market. Some of these are listed below.


It is estimated that out of the patients who need organ transplants, only 10% are provided with transplants and replacements. This has resulted in a long waiting list for the respective transplants to take place. This has been a major plus point for the artificial organs market. Some of the other factors contributing to the growth of this market are:

Rapidly aging global population

Increasing number of people suffering from organ failures

Rising incidents of motor accidents and other work-related accidents

Increasing technological advancements in the artificial organs sector

Scarcity of donor organs for those in need


The major restraints for the market are:

Regulatory requirements for artificial organs

Inherent expense of these products to the patients who need them

Fear of device malfunction or failure

Criticism from certain health sector personnel advising against the use of artificial organs

The global artificial organs market includes the markets for vital organs, such as the heart, kidney, liver, and pancreas. Geographically, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. Among these, the North American region holds the largest market share, owing to the high per capita income in this region and the higher awareness levels among the population. Following North America, Europe is the second largest market. APAC is a market with immense potential. The need for artificial organs is higher in this region than in other regions.

Some of the key players in the market are:

Esko Bionics

F Hoffman-La Roche Ltd

Gambro AB

Iwalk Inc.

Jarvik Heart

Lifenet Health


Nano Retina, Inc.

Key Deliverables in the Study

Global, regional and country-level analysis along with forecasts of the study market.

Study of the effect of exogenous & endogenous factors, viz. demographic, economic, and political factors, among others, which affect the global market.

Porterfive forces framework incorporating the factors influencing each force to determine the intensity of competition.

Segment and sub-segment level analysis of the market for the review and forecast period.

Identification of key factors instrumental in changing the market scenario, exploiting new opportunities and gaining a competitive edge.

SWOT analysis for key players and a detailed study of their current strategic interests and key financial performance indicators.

1. Introduction

1.1 Report Description

1.2 Research Methodology

1.3 Major Stakeholders

2. Executive Summary

2.1 Key Findings

2.2 Market Overview

3. Market Overview

3.1 Market Definition

3.1.1 Introduction

3.2 Market Drivers

3.2.1 Scarcity of Donor Organs

3.2.2 Increased incidence of disabilities & organ failures

3.2.3 Technological Advancements

3.2.4 Rapidly aging population

3.3 Market Restraints

3.3.1 Expensive procedures

3.3.2 Fear of device malfunction and its consequences

4. Market Segmentation: Artificial Organs

4.1 Artificial Heart

4.1.1 Prosthetic Heart Valves

4.1.2 Ventricular Assist Devices

4.2 Artificial Kidney

4.2.1 Dialysis

4.3 Artificial Livers

4.3.1 Liver Dialysis

4.3.2 Bioartificial Liver Device (BAL)

4.3.3 Molecular Adsorbent Recirculation Systems (MARS)

4.3.4 Single Pass Albumin Dialysis (SPAD)

4.3.5 Prometheus

4.4 Artificial Pancreas

4.4.1 Insulin Pump

4.5 Artificial Lungs

4.5.1 Extracorporeal membrane oxygenation

4.5.2 Heart-Lung Machines

5. Market Segmentation: Geography

5.1 North America

5.1.1 USA

5.1.2 Canada

5.2 Europe

5.2.1 UK

5.2.2 Germany

5.2.3 France

5.2.4 Spain

5.2.5 Italy

5.2.6 Others

5.3 APAC

5.3.1 South Korea

5.3.2 Japan

5.3.3 China

5.3.4 India

5.3.5 Australia

5.3.6 Others

5.4 Rest of the World

6. Competitive Landscape

6.1 Mergers & Acquisitions

6.2 New Product Launches

6.3 Agreements, Collaborations & Partnerships

6.4 Market Chain Analysis

6.5 Price Share Analysis

7. Company Profiles

7.1 Abiomed Inc.

7.2 Asahi Kasei Medical Co., Ltd

7.3 Baxter International, Inc.

7.4 Berlin Heart GmbH

7.5 Boston Scientific Corporation

7.6 Cochlear Limited

7.7 Cyberonics

7.8 Edward Lifesciences Corporation

7.9 Esko Bionics

7.10 F Hoffman-La Roche Ltd

7.11 Gambro AB

7.12 Iwalk Inc

7.13 Jarvik Heart

7.14 Medtronic

7.15 Lifenet Health

7.16 Nano Retina, Inc.

7.17 Ossur

7.18 Otto Bock Healthcare GmbH

7.19 Second Sight Medical Products

7.20 Thoratec Corporation

7.21 Touch Bionics

7.22 Worldheart Corporation

8. Appendix

8.1 Abbreviations

8.2 Sources

8.3 Bibliography

8.4 Disclaimer

Content are not available

Choose License Type